Recombinant Human FA2H, MYC/DDK-tagged

• Cat.No.: FA2H-891H
• Product Overview: Recombinant Human FA2H fused with C-terminal MYC/DDK, was expressed in HEK293 Cells.

Specification

• Cat. No.: FA2H-891H
• Description: This gene encodes a protein that catalyzes the synthesis of 2-hydroxysphingolipids, a subset of sphingolipids that contain 2-hydroxy fatty acids. Sphingolipids play roles in many cellular processes and their structural diversity arises from modification of the hydrophobic ceramide moiety, such as by 2-hydroxylation of the N-acyl chain, and the existence of many different head groups. Mutations in this gene have been associated with leukodystrophy dysmyelinating with spastic paraparesis with or without dystonia.
• Source: HEK293 Cells
• Molecular Mass: 42.6 kDa
• Purity: >80% as determined by SDS-PAGE and Coomassie blue staining
• Storage buffer: 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10% glycerol.
• Concentration: >50 ug/mL as determined by microplate BCA method
• Preparation: Recombinant protein was captured through anti-DDK affinity column followed by conventional chromatography steps.
• Storage: Store at -800C. Avoid repeated freeze-thaw cycles. Stable for at least 3 months from receipt of products under proper storage and handling conditions.
• OfficialSymbol: FA2H

Gene Information

• Gene Name: FA2H fatty acid 2-hydroxylase [ Homo sapiens ]
• Synonyms: FA2H; fatty acid 2-hydroxylase; FAAH; FAH1; SCS7; SPG35; FAXDC1; fatty acid alpha-hydroxylase; fatty acid hydroxylase domain containing 1; spastic paraplegia 35 (autosomal recessive); EC 1.-.-.-; FLJ25287
• Gene ID: 79152
• mRNA Refseq: NM_024306
• Protein Refseq: NP_077282
• MIM: 611026
• UniProt ID: Q7L5A8
• Chromosome Location: 16q23
• Function: fatty acid alpha-hydroxylase activity; heme binding; iron ion binding